These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4231460)

  • 1. Theoretical basis and standardization of the one-stage lysis time method for determination of urokinase.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1968 Mar; 19(1):169-77. PubMed ID: 4231460
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolysis: kinetics of the lysis of a fibrin clot].
    Daver J; Edmond E; Panak E; Ricoeur M
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):333-42. PubMed ID: 4246032
    [No Abstract]   [Full Text] [Related]  

  • 3. A method to correct for the continuing activation during the second stage in a two-stage assay. Exemplified by urokinase activation of plasminogen determined by the lysis time method.
    Berg W
    Thromb Diath Haemorrh; 1968 Mar; 19(1):161-8. PubMed ID: 4231459
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies.
    Berg W
    Acta Med Scand Suppl; 1967; 478():1-45. PubMed ID: 4231608
    [No Abstract]   [Full Text] [Related]  

  • 5. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen assay by means of the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the fibrinolytic action of heparin substance in man].
    De Nicola P; Gibelli A; Turazza G; Nadile L
    Arzneimittelforschung; 1965 Dec; 15(12):1430-3. PubMed ID: 4225447
    [No Abstract]   [Full Text] [Related]  

  • 8. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiology of hemostasis. II. Fibrinolysis].
    Sultan Y; Caen J; Allain JP; Meyer D
    Pathol Biol (Paris); 1969 May; 17(9):529-34. PubMed ID: 4240805
    [No Abstract]   [Full Text] [Related]  

  • 10. Assay of the antifibrinolytic activity in human plasma by means of the lysis time method.
    Ygge J; Berg W; Korsan-Bengtsen K
    Thromb Diath Haemorrh; 1968 Dec; 20(3):561-73. PubMed ID: 4237141
    [No Abstract]   [Full Text] [Related]  

  • 11. Histochemistry and assay of plasminogen activator.
    Pandolfi M
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):254-60. PubMed ID: 4262311
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
    Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
    [No Abstract]   [Full Text] [Related]  

  • 13. [A method for separation of plasminogen from bovine plasma fraction. I. With reference to some properties of the plasminogen].
    Okamoto U; Matumoto M
    Nihon Seirigaku Zasshi; 1971; 33(7):394-402. PubMed ID: 4255047
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Thromb Diath Haemorrh; 1968 Mar; 19(1):129-35. PubMed ID: 5652223
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase activation of plasminogen and spontaneous inactivation of the plasmin formed. A kinetic study.
    Berg W
    Thromb Diath Haemorrh; 1968 Mar; 19(1):145-60. PubMed ID: 4231458
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision.
    Jespersen J; Astrup T
    Haemostasis; 1983; 13(5):301-15. PubMed ID: 6360818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methods for the determination of pathological hyperfibrinolysis of the blood].
    Perlick E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):171-85. PubMed ID: 4098771
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state.
    Spöttl F; Holzknecht F
    Thromb Diath Haemorrh; 1970 Oct; 24(1):101-12. PubMed ID: 4249466
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of bioresolving microspheric preparations of immobilized fibrinolysin on the fibrinolysis system].
    Bessolitsyna LA; Mazaev AB; Markosian RA; Suvorov AV; Torchilin VP
    Biull Eksp Biol Med; 1980; 89(1):16-8. PubMed ID: 6445763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.